Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Predictors of sildenafil effects on exercise capacity in adolescents and adults with Fontan circulation.

Hager A, Weber R, Müller J, Hess J.

Clin Res Cardiol. 2014 Aug;103(8):641-6. doi: 10.1007/s00392-014-0694-2. Epub 2014 Mar 18.

PMID:
24639042
2.

Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.

Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM.

Eur Heart J. 2008 Jul;29(13):1681-7. doi: 10.1093/eurheartj/ehn215. Epub 2008 Jun 4.

PMID:
18534975
3.

Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.

Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J.

Circulation. 2011 Mar 22;123(11):1185-93. doi: 10.1161/CIRCULATIONAHA.110.981746. Epub 2011 Mar 7.

4.

Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.

Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, Sørensen KE, Søndergaard L.

Circulation. 2014 Dec 2;130(23):2021-30. doi: 10.1161/CIRCULATIONAHA.113.008441. Epub 2014 Oct 20.

5.

Sildenafil improves exercise hemodynamics in Fontan patients.

Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W.

Circ Cardiovasc Imaging. 2014 Mar;7(2):265-73. doi: 10.1161/CIRCIMAGING.113.001243. Epub 2014 Jan 29.

6.

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.

Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ.

Circulation. 2007 Jan 2;115(1):59-66. Epub 2006 Dec 18.

7.
8.

Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.

Robbers-Visser D, Kapusta L, van Osch-Gevers L, Strengers JL, Boersma E, de Rijke YB, Boomsma F, Bogers AJ, Helbing WA.

J Thorac Cardiovasc Surg. 2009 Jul;138(1):89-95. doi: 10.1016/j.jtcvs.2008.12.027. Epub 2009 Feb 23.

10.

Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection.

Hager A, Christov F, Hess J.

Pediatr Cardiol. 2012 Jun;33(5):764-9. doi: 10.1007/s00246-012-0210-2. Epub 2012 Feb 29.

PMID:
22374379
11.

Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.

Yang-Ting S, Aboulhosn J, Sun XG, Child JS, Sietsema KE.

Congenit Heart Dis. 2011 Mar-Apr;6(2):139-46. doi: 10.1111/j.1747-0803.2011.00490.x. Epub 2011 Mar 21.

PMID:
21418531
12.

Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude.

Jacobs KA, Kressler J, Stoutenberg M, Roos BA, Friedlander AL.

High Alt Med Biol. 2011 Fall;12(3):215-22. doi: 10.1089/ham.2011.0011.

PMID:
21962064
13.

Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.

Trojnarska O, Gwizdała A, Katarzyński S, Katarzyńska A, Szyszka A, Lanocha M, Grajek S, Kramer L.

Cardiol J. 2009;16(2):133-41.

14.

Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.

Heck PB, Müller J, Weber R, Hager A.

Eur J Heart Fail. 2013 Jun;15(6):644-9. doi: 10.1093/eurjhf/hft063. Epub 2013 Apr 21.

15.

Effects of sildenafil on cardiopulmonary responses during stress.

Stanopoulos I, Hatzichristou D, Tryfon S, Tzortzis V, Apostolidis A, Argyropoulou P.

J Urol. 2003 Apr;169(4):1417-21.

PMID:
12629375
16.

Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.

Hager A, Fratz S, Hess J.

Eur Heart J. 2009 Feb;30(4):507-8; author reply 508. doi: 10.1093/eurheartj/ehp035. Epub 2009 Jan 31. No abstract available.

PMID:
19182238
17.

Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation.

Goldstein BH, Connor CE, Gooding L, Rocchini AP.

Am J Cardiol. 2010 Apr 15;105(8):1169-75. doi: 10.1016/j.amjcard.2009.12.020. Epub 2010 Feb 20.

PMID:
20381672
18.

Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure.

Sperandio PA, Oliveira MF, Rodrigues MK, Berton DC, Treptow E, Nery LE, Almeida DR, Neder JA.

Am J Physiol Heart Circ Physiol. 2012 Dec 15;303(12):H1474-80. doi: 10.1152/ajpheart.00435.2012. Epub 2012 Sep 28.

19.

Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.

Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ.

Eur J Heart Fail. 2013 Jun;15(6):690-8. doi: 10.1093/eurjhf/hft017. Epub 2013 Jan 29.

20.

Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?

Schuuring MJ, Vis JC, Bouma BJ, van Dijk AP, van Melle JP, Pieper PG, Vliegen HW, Sieswerda GT, Mulder BJ.

Contemp Clin Trials. 2011 Jul;32(4):586-91. doi: 10.1016/j.cct.2011.04.001. Epub 2011 Apr 17.

PMID:
21527360

Supplemental Content

Support Center